Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
840.00
-5.00
(-0.59%)
At close: February 21 at 3:30:00 PM GMT+9
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-782,000
-5,273,000
9,952,000
7,095,000
4,672,000
Investing Cash Flow
-61,605,000
-63,791,000
1,043,000
278,000
-150,000
Financing Cash Flow
44,938,000
48,329,000
-4,887,000
11,123,000
20,278,000
End Cash Position
48,149,000
49,065,000
66,557,000
60,087,000
40,008,000
Capital Expenditure
-744,000
-851,000
-303,000
-201,000
-105,000
Issuance of Capital Stock
--
9,983,000
--
600,000
5,145,000
Issuance of Debt
--
71,608,000
--
29,855,000
15,902,000
Repayment of Debt
-35,800,000
-32,750,000
--
-18,958,000
--
Free Cash Flow
-1,526,000
-6,124,000
9,649,000
6,894,000
4,567,000
12/31/2020 - 7/29/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4587.T PeptiDream Inc.
2,116.00
+1.15%
SRZN Surrozen, Inc.
11.20
-3.03%
IRON Disc Medicine, Inc.
54.53
+0.33%
RYTM Rhythm Pharmaceuticals, Inc.
56.07
-2.89%
FYB.DE Formycon AG
28.30
-4.71%
CGEM Cullinan Therapeutics, Inc.
9.03
-1.31%
ALVR AlloVir, Inc.
9.63
-0.41%
OABI OmniAb, Inc.
3.6500
-5.93%
ARGX.BR argenx SE
618.20
-0.16%
PVLA Palvella Therapeutics, Inc.
19.22
+1.16%